Status:
RECRUITING
NorMIGS - a Study of Micro-invasive Glaucoma Surgery
Lead Sponsor:
Oslo University Hospital
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Brief Summary
NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conduc...
Eligibility Criteria
Inclusion
- Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
- Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS
- Ability to cooperate fairly well during the examinations
- Willing to participate in the study and capable of providing informed consent
Exclusion
- \- High intraocular pressure due to increased episcleral venous pressure, hemorrhagic glaucoma, traumatic glaucoma or uveitis glaucoma
Key Trial Info
Start Date :
April 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05340647
Start Date
April 22 2022
End Date
June 1 2028
Last Update
November 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Oslo University Hospital
Oslo, Norway, 1163